Tempest Therapeutics TPST Cash Flow Statement (2012-2026)

NASDAQ TPST
$0.54 +0.01 (+2.54%)
As of: Oct 22, 2026 · 1:18 PM EDT
Reported Financials

Tempest Therapeutics Quarterly Cash Flow Statement

Periods 57 quarters
Latest Jun 2026

Tempest Therapeutics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 57 quarters of results from Mar 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-7.06M-8.11M-28.30M-8.49M-9.17M-8.95M-9.10M-7.64M-7.58M-6.79M-7.49M-7.90M-9.57M-10.56M-13.81M-10.86M-7.87M-3.51M-4.02M-5.24M
Depreciation and DepletionDep. & Depletion
0.09M0.11M0.10M0.11M0.11M0.20M0.22M0.13M0.08M0.09M0.09M0.09M0.16M0.10M0.05M0.07M0.07M0.07M0.07M0.06M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.09M0.11M0.10M0.11M0.11M0.20M0.22M0.13M0.08M0.09M0.09M0.09M0.16M0.10M0.05M0.07M0.07M0.07M0.07M0.06M
Share-based CompensationStock Comp.
0.41M0.30M0.28M0.33M0.37M0.44M0.43M0.45M0.44M0.56M1.10M1.32M1.32M1.33M1.33M1.39M1.09M0.06M0.58M-0.12M
Gains from Equity InvestmentsGains Equity
Gains from Sales and DivestituresGains Divest
Asset Writedowns and ImpairmentWritedown
Other non-cash itemsOther Non-Cash
0.14M0.32M0.31M0.31M0.30M0.24M0.32M0.43M0.41M0.42M0.43M0.44M0.35M0.26M0.26M0.27M0.27M0.28M0.29M
Change in Working Capital
Change in Account PayablesChange Payables
5.76M-4.32M-1.34M-0.32M0.76M-0.53M0.09M0.01M-0.25M0.27M-0.29M0.21M0.31M0.34M0.75M-0.26M2.53M-3.79M0.12M
Change in Accured ExpensesChange Accured Exp.
-0.72M0.83M1.09M1.06M-0.74M0.62M0.76M-1.21M0.28M-0.35M0.29M-1.00M1.30M-0.65M1.63M1.22M-4.38M0.13M-0.37M
Change in Other Operating AssetsOther Assets Change
-1.34M0.80M0.37M-0.18M-0.27M0.78M-1.25M0.03M-0.40M0.22M-0.04M0.04M-0.75M0.66M0.16M-0.23M-0.11M-0.24M-0.03M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.11M-0.35M-0.34M-0.35M-0.49M-0.37M-0.29M-0.50M-0.22M-0.52M-0.39M-0.34M-0.17M-0.37M-0.22M-0.10M-0.25M-0.26M-0.26M
Other Working Capital ChangesOther WC Changes
1.23M-1.15M-0.71M-0.17M-0.22M-1.15M0.96M-0.53M0.18M-0.74M-0.35M-0.38M0.58M-1.03M-0.38M0.14M-0.14M-0.02M-0.23M
Cash from OperationsCash from Ops.
0.13M-11.79M-7.99M-7.11M-8.41M-9.07M-6.48M-8.30M-6.39M-6.49M-6.18M-7.19M-5.51M-10.18M-10.15M-8.04M-8.43M-6.78M-3.57M
Investing Activities
Capital ExpendituresCapex
0.07M0.02M0.03M0.00M0.10M0.11M0.36M0.05M0.12M0.01M0.17M0.25M0.02M0.00M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-0.07M-0.02M-0.03M0.00M-0.10M-0.11M-0.36M-0.05M-0.12M-0.01M-0.17M-0.25M-0.02M0.00M
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
Other Investing ActivitiesOther investing
0.04M
Cash from Investing ActivitiesCash from Investing
-0.07M0.01M-0.03M0.00M-0.10M-0.11M-0.36M-0.05M-0.12M-0.01M-0.17M-0.25M-0.02M0.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
2.20M2.20M2.20M4.23M
Non-Current Debt
-2.20M-2.20M-2.20M-4.23M
Net Debt Issuances and RepaymentsNet Debt Issuance
-2.20M-2.20M-2.20M-4.23M
Change in Capital Stock
Common Stock IssuedStock Issued
30.02M3.51M-0.01M1.40M14.38M0.35M0.01M0.04M1.19M0.02M34.35M0.45M4.56M3.74M20.15M1.48M-1.44M6.88M2.48M
Net Shares Issued and RepurchasedNet Shares Issued
30.02M3.51M-0.01M1.40M14.38M0.35M0.01M0.04M1.19M0.02M34.35M0.45M4.56M3.74M20.15M1.48M-1.44M6.88M2.48M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
30.02M3.51M-0.01M1.40M14.38M0.35M0.01M0.04M1.19M0.02M34.35M0.45M4.56M3.74M20.15M1.48M-1.44M6.88M2.48M
Other financing activitiesOther financing
-6.11M-0.35M17.04M
Cash from Financing ActivitiesCash from Financing
40.96M3.17M-0.01M1.40M14.38M0.35M-4.73M0.04M1.19M0.02M34.35M0.45M4.56M1.54M17.95M-0.72M1.20M0.01M3.77M
Additional items
Exchange Rate EffectFX Effect
Change in Cash
41.02M-8.70M-7.93M-5.71M5.87M-8.83M-11.56M-8.31M-5.32M-6.47M28.17M-6.90M-1.20M-8.66M7.80M-8.76M-7.23M-6.77M0.19M
Ending Cash Balance
68.46M59.76M51.83M46.12M51.99M43.16M31.60M23.29M17.97M11.51M39.67M32.77M31.57M22.91M30.71M21.95M14.72M7.96M8.15M1.22M
Free Cash FlowFCF
0.06M-11.81M-8.01M-7.11M-8.51M-9.18M-6.84M-8.35M-6.51M-6.49M-6.18M-7.35M-5.76M-10.20M-10.15M-8.04M-8.43M-6.78M-3.57M
Net Cash FlowNCF
41.02M-8.61M-8.02M-5.71M5.87M-8.83M-11.56M-8.31M-5.32M-6.47M28.17M-6.90M-1.20M-8.66M7.80M-8.76M-7.23M-6.77M0.19M
Interest Paid
0.28M0.30M0.27M0.27M0.29M0.34M0.65M0.29M0.31M0.32M0.32M0.33M0.33M0.30M0.22M0.15M0.04M
Income Taxes PaidTaxes Paid
0.02M0.02M0.08M0.05M

Tempest Therapeutics Cash Flow Statement API

Pull Tempest Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TPST&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY